Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Application of the revised Tumour Node Metastasis (TNM) staging system of clear cell renal cell carcinoma in eastern China: advantages and limitations.

Qin C, Sun LJ, Cui L, Cao Q, Zhu J, Li P, Zhang GM, Mao X, Shao PF, Wang ML, Zhang ZD, Gu M, Zhang W, Yin CJ.

Asian J Androl. 2013 Jul;15(4):550-7. doi: 10.1038/aja.2012.161. Epub 2013 Apr 8.

2.

External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.

Zigeuner R, Hutterer G, Chromecki T, Imamovic A, Kampel-Kettner K, Rehak P, Langner C, Pummer K.

Eur Urol. 2010 Jan;57(1):102-9. doi: 10.1016/j.eururo.2008.11.033. Epub 2008 Nov 28.

PMID:
19062157
3.

Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.

Belldegrun A, Tsui KH, deKernion JB, Smith RB.

J Clin Oncol. 1999 Sep;17(9):2868-75.

PMID:
10561364
4.

Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system.

Gettman MT, Blute ML, Spotts B, Bryant SC, Zincke H.

Cancer. 2001 Jan 15;91(2):354-61.

PMID:
11180082
5.

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.

Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A.

J Urol. 2000 Apr;163(4):1090-5; quiz 1295.

PMID:
10737472
6.

Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma.

Eisenberg MS, Cheville JC, Thompson RH, Kaushik D, Lohse CM, Boorjian SA, Costello BA, Leibovich BC.

J Urol. 2013 Jul;190(1):37-43. doi: 10.1016/j.juro.2013.01.044. Epub 2013 Jan 23.

7.

Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.

Roos FC, Weirich J, Victor A, Elsässer A, Brenner W, Biesterfeld S, Hampel C, Thüroff JW.

BJU Int. 2009 Aug;104(4):461-9. doi: 10.1111/j.1464-410X.2009.08489.x. Epub 2009 Mar 11.

8.

Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.

Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM.

J Urol. 2001 Jul;166(1):68-72.

PMID:
11435825
9.

Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).

Antonelli A, Arrighi N, Corti S, Legramanti S, Zanotelli T, Cozzoli A, Cunico SC, Simeone C.

BJU Int. 2012 Dec;110(11 Pt B):E559-63. doi: 10.1111/j.1464-410X.2012.11271.x. Epub 2012 May 28.

10.

Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma.

Pichler M, Hutterer GC, Chromecki TF, Jesche J, Kampel-Kettner K, Groselj-Strele A, Hoefler G, Pummer K, Zigeuner R.

Histopathology. 2013 Jan;62(2):237-46. doi: 10.1111/his.12001. Epub 2012 Sep 28.

PMID:
23020176
11.

Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.

Krejci KG, Blute ML, Cheville JC, Sebo TJ, Lohse CM, Zincke H.

Urology. 2003 Oct;62(4):641-6. Review.

PMID:
14550434
12.

Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?

Ficarra V, Novara G, Galfano A, Novella G, Schiavone D, Artibani W.

Urology. 2004 Jun;63(6):1050-4.

PMID:
15183948
13.

Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.

Jorns J, Thiel DD, Lohse CM, Williams A, Arnold ML, Cheville JC, Leibovich BC, Parker AS.

BJU Int. 2012 Oct;110(7):956-60. doi: 10.1111/j.1464-410X.2012.10937.x. Epub 2012 Feb 2.

14.

Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.

Lau WK, Cheville JC, Blute ML, Weaver AL, Zincke H.

Urology. 2002 Apr;59(4):532-7.

PMID:
11927308
15.

The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.

Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.

J Urol. 2002 Jul;168(1):56-60.

PMID:
12050492
16.

Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.

Shindo T, Masumori N, Kobayashi K, Fukuta F, Hirobe M, Tonooka A, Hasegawa T, Kitamura H, Tsukamoto T.

BJU Int. 2013 May;111(6):941-5. doi: 10.1111/j.1464-410X.2012.11771.x. Epub 2013 Jan 25.

17.

Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V; Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.

BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.

18.
19.
20.

The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma.

Capitanio U, Matloob R, Suardi N, Abdollah F, Castiglione F, Di Trapani D, Russo A, Briganti A, Carenzi C, Salonia A, Montorsi F, Rigatti P, Bertini R.

Urologia. 2012 Apr-Jun;79(2):109-15. doi: 10.5301/RU.2012.9255.

PMID:
22610843
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk